HC Bioscience, Inc.’s Post

It's clear that the Annual Meeting is more than just a conference; it's a catalyst for sparking ideas, forming relationships, and advancing progress. As Joe Lewcock, Ph.D., Chief Scientific Officer of Denali Therapeutics, eloquently expressed, "I can see it's been incredibly impactful to be involved, not just through the consortia... but through the relationships we've built at this meeting." Together, we're driving groundbreaking advancements in ALS research. #ALSResearch #EveryoneLives #ALS #EndALS #ALSAwarenessMonth

If you or anyone you know is looking for some lab space to jumpstart your research, please reach out! ABI Lab is the place to be ✨ If you don’t believe me, check out this most recent news letter by MetroWest Daily News!

❗𝗪𝗔𝗥𝗡𝗜𝗡𝗚: 2 Discounted Passes Left for the 𝟲𝘁𝗵 𝗠𝗮𝗰𝗿𝗼𝗽𝗵𝗮𝗴𝗲-𝗗𝗶𝗿𝗲𝗰𝘁𝗲𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝗦𝘂𝗺𝗺𝗶𝘁!   Time is running out to be part of the 𝗺𝗼𝘀𝘁 𝗰𝗿𝘂𝗰𝗶𝗮𝗹 𝗲𝘃𝗲𝗻𝘁 𝗶𝗻 𝗺𝗮𝗰𝗿𝗼𝗽𝗵𝗮𝗴𝗲 𝘁𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀. Don't risk falling behind as top experts 𝗰𝗼𝗻𝗳𝗿𝗼𝗻𝘁 𝘁𝗵𝗲 𝗺𝗼𝘀𝘁 𝗽𝗿𝗲𝘀𝘀𝗶𝗻𝗴 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲𝘀 and share their 𝘀𝗲𝗰𝗿𝗲𝘁𝘀 𝗼𝗻 𝗶𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁𝘀 𝗮𝗻𝗱 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝘀𝗵𝗶𝗽𝘀.   𝗚𝗿𝗮𝗯 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗽𝗿𝗼𝗴𝗿𝗮𝗺 - https://ter.li/ntamqp   Once these 2 passes are gone, so is your chance to stay ahead in this fast-evolving field.   ⏳ 𝗦𝗮𝘃𝗲 $𝟯𝟬𝟬 𝗯𝘆 𝗺𝗶𝗱𝗻𝗶𝗴𝗵𝘁 𝘁𝗼𝗺𝗼𝗿𝗿𝗼𝘄 - https://ter.li/ook4wg   Don't let this opportunity slip away!   #MacrophageDirectedTherapiesSummit

Discover how leading life science companies are overcoming challenges and raising significant funds to drive innovation! This panel will feature industry leaders discussing their unique scientific pursuits, products, and the financial and regulatory hurdles in today’s competitive life sciences market. 🎤 Speakers include: Jang-Ho Cha, Latus Therapeutics Josh Muntner, CFO, Imvax, Inc. Moderated by John Pennett, EisnerAmper Advisory Services. Join us for this insightful session at the Philly Builds Bio+ Third Annual Symposium! 🔗 Register today: phillybuildsbio.org #PhillyBuildsBio #LifeSciences #InvestmentOpportunities #FinancingSuccess #BiotechInnovation

Listen to our CEO's conversation to learn more about our journey and mission to map the therapeutic potential of secreted proteins and engineer them as biologics that promote tissue health function to treat chronic metabolic and muscle diseases!

I am participating LSN Webinar to share my two cents on growing interest of JP startups/biotechs on Go-to-market strategy abroad and what improvement is needed to achieve it.

💥💥New Publication Alert💥💥 I'm excited to share our newly published paper titled "Progress of Phage Therapy Research as an Alternative to Antibiotics: Current Status, Challenges, and The Future of Phage Therapeutics". I appreciate the big contributions of my co-authors: Samuel Awoniyi, Bisola Bolarinde, and Awotimiro Oluwafemi I also acknowledge the support of the Young Researchers' Hub - OAU, under the leadership of Taiwo Sokunbi. Here's the link to the full article: https://lnkd.in/eE8SVa83 #publichealth #AMR #phagetherapyawareness #bacteriophages

What is it like to live with thyroid eye disease (TED)? Viridian Therapeutics, Inc. is studying multiple candidates in clinical studies for TED, and recently met with a group of individuals living with TED to gain a deeper understanding about their lived experiences. The image below shares some of what the company learned about people's varied and individualized journeys with the disease. Learn more at https://lnkd.in/eZTGdQ9m #biotech #TED

A big day at Juvena Therapeutics, as their lead candidate, JUV-161, has received positive FDA feedback and Orphan Disease Designation (ODD) for the treatment of Myotonic Dystrophy Type 1 (DM1). This is a major win for the broader ecosystem as an example of how founder-led biotech can truly change how we think of addressing unmet medical needs. As an early investor, I take immense pride in the team's dedicated efforts over the course of five and a half years, involving hard work and determination, to establish a world-class, fully integrated platform for the discovery and development of biologics. Their unique approach to repairing and restoring muscle health with a biologic that enhances muscle regeneration, metabolism, and function, countering the effects of aging and degenerative disease. Congrats Hanadie Yousef, Jeremy O'Connell, Neil Berkley, Mo Tabrizi, all the scientists, biologists, engineers, rest of the team, other investors, and the many partners who have believed in this group. Big things ahead!!! 🚀 Link to the announcement: https://lnkd.in/gvRTC2NS #biotech #venturecapital #founderled #healthcare #MyotonicDystrophy #RareDisease #unmetmedicalneed #healthspan #sarcopenia

In a recent interview with China's leading healthcare industry outlet 动脉网 VCBeat, our Partner kan chen, PhD shared the strategy, approach and considerations for Qiming when investing in innovative therapeutics. #QMinsights #Qiminginsights #Chinahealthcare #healthcareinvestment #drugdevelopment